Miyajima, Hiroaki

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., & Gitlin, J. D. (1995) · Proceedings of the National Academy of Sciences

Neurological diseases and metabolismTrace Elements in Health

Cited by 558

Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis

Shiva, S., Wang, X., Ringwood, L. A., Xu, X., Yuditskaya, S., Annavajjhala, V., Miyajima, H., Hogg, N., Harris, Z. L., & Gladwin, M. T. (2006) · Nature Chemical Biology

Nitric Oxide and Endothelin EffectsHemoglobin structure and function

Cited by 359

Use of desferrioxamine in the treatment of aceruloplasminemia

Miyajima, H., Takahashi, Y., Kamata, T., Shimizu, H., Sakai, N., & Gitlin, J. D. (1997) · Annals of Neurology

Neurological diseases and metabolismIron Metabolism and Disorders

Cited by 173

Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation

Suzuki, Y., Yoshida, K., Aburakawa, Y., Kuroda, K., Kimura, T., Terada, T., Kono, S., Miyajima, H., & Yahara, O. (2013) · Internal Medicine

Neurological diseases and metabolismIron Metabolism and Disorders

Cited by 35